Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization

The combination of filgrastim (G-CSF) and plerixafor is currently approved for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin lymphoma and multiple myeloma undergoing autologous peripheral blood hematopoietic cell transplantation. However, chemotherapy and G-CSF-based mobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Awan, Farrukh T., Kochuparambil, S. Thomas, DeRemer, David, Cumpston, Aaron, Craig, Michael, Jillella, Anand, Hamadani, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335320/
https://www.ncbi.nlm.nih.gov/pubmed/22570654
http://dx.doi.org/10.1155/2012/931071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335320/
https://www.ncbi.nlm.nih.gov/pubmed/22570654
http://dx.doi.org/10.1155/2012/931071

Ejemplares similares